Abiomed (ABMD) 60.39 $ABMD
Varian Medical's ProBeam Proton Therapy Now in Denmark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 2:43PM CST
In addition to the ProBeam system, Varian Medical Systems Inc. (VAR) will provide the Denmark center with its ARIA information management software.
ABMD: 60.39 (+0.46), VAR: 92.65 (+0.03), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Allscripts Sunrise EHR: IHMC's Choice for Flagship Hospital - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 1:57PM CST
Allscripts recently announced that its Sunrise Acute Care has been selected by Texas-based International Hospital Management Corp. (IHMC).
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), MDRX: 11.80 (+0.04), SURG: 4.44 (-0.02)
Bioanalytical Systems' Breakeven Q1 Earnings, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:00AM CST
Bioanalytical Systems (BASI) reported adjusted breakeven earnings per share (EPS) in the first quarter of fiscal 2015, which was lower by 3 cents on a year-over-year basis
ABMD: 60.39 (+0.46), BASI: 2.06 (+0.18), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Alere (ALR) Disappoints; Misses on Earnings, Revenues in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:44AM CST
Alere Inc. (ALR) reported disappointing fourth-quarter 2014 results with both its top and bottom line missing the Zacks Consensus Estimate.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ALR: 43.40 (-0.40), SURG: 4.44 (-0.02)
Cepheid Strong on Q4, Global Expansion; Currency Woes Stay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 1:09PM CST
Cepheid (CPHD) reported adjusted breakeven earnings per share in the quarter, which compared favorably with the Zacks Consensus Estimate of a loss of 14 cents.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), CPHD: 59.62 (+0.72), LMNX: 15.45 (+0.02)
Acadia Healthcare Posts In-Line Q4 Earnings, Revenue Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:54AM CST
Acadia Healthcare Company (ACHC) reported fourth-quarter 2014 adjusted earnings (EPS) of 46 cents per share, which surged an impressive 58.6% year over year.
ACHC: 63.20 (-0.45), ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Thoratec (THOR) Catches Eye: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:08AM CST
Thoratec Corp. (THOR) was a big mover last session, as the company saw its shares rise over 8% on the day.
ABMD: 60.39 (+0.46), THOR: 40.01 (+0.54)
MVPVets Veterans Program Recognizes Top Donors in 2014
GlobeNewswire - Wed Feb 11, 9:55AM CST
MVPVets (The MedTech and BioTech Veterans Program) is recognizing top donors for the program in 2014. MVPVets, a 501(c)(3) nonprofit organization, provides training and mentorship to veterans and transitioning military in order to help them recareer into rewarding jobs in Life Sciences industry. Wholly sponsored by grants and the Medical Device and Technology, Biological Technological, Pharmaceutical, and other segments within the Life Sciences industry, the program partners with host companies for one-day recareering seminars and provides virtual mentorship and training through the MVPVets collaborative online portal.
ABMD: 60.39 (+0.46)
Thoratec Beats Q4 Earnings and Revenues, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:45AM CST
Shares of Thoratec Corp. (THOR) rallied 4.37% ($1.59) to $38.00 after the company reported impressive fourth-quarter financial numbers.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), THOR: 40.01 (+0.54), LMNX: 15.45 (+0.02)
Opko Health (OPK) in Focus: Stock Jumps 5.3% - Tale of the Tape
Zacks Research Stuff - Zacks Investment Research - Tue Feb 10, 8:18AM CST
Opko Health, Inc. (OPK) was a big mover last session, as the company saw its shares rise over 5% on the day.
ABMD: 60.39 (+0.46), OPK: 13.80 (-0.28)
Sirona Dental Q1 Earnings and Revenues Top Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:45AM CST
Following the earnings release, shares of Sirona Dental Systems Inc. (SIRO) dropped nearly 3.4% to close at $90.25 till the last trading session.
SIRO: 91.06 (+0.18), ABMD: 60.39 (+0.46), PDCO: 50.65 (-0.16), HSIC: 143.18 (+0.72)
Fluidigm Q4 Loss Narrower Than Expected, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:10AM CST
Following the earnings announcement on Feb 5, shares of Fluidigm Corp (FLDM) rallied nearly 2.8% to open at $39.85 on Friday.
ABMD: 60.39 (+0.46), FLDM: 37.93 (-0.47), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Accuray's TomoTherapy Gains Traction in Latin America (Revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:00AM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ARAY: 8.00 (+0.24), LMNX: 15.45 (+0.02)
Invacare (IVC) Reports Narrower Q4 Loss, Beats on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:29AM CST
Invacare Corp. (IVC) reported adjusted loss of 12 cents per share in the fourth quarter of 2014, which was narrower than the Zacks Consensus Estimate of a loss of 23 cents
ABMD: 60.39 (+0.46), IVC: 17.13 (+0.15), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Mettler-Toledo Tops Earnings, Revenues on Margin Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:16AM CST
Mettler-Toledo International Inc. (MTD) reported an impressive fourth-quarter 2014 wherein adjusted EPS of $4.24 beat the Zacks Consensus Estimate by 9 cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02), MTD: 307.00 (-0.13)
Accuray's TomoTherapy Gains Traction in Latin America - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 5:25PM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02), ARAY: 8.00 (+0.24)
Affymetrix (AFFX) Earnings, Revenues Outshine Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 8:56AM CST
Affymetrix Inc. (AFFX) reported adjusted earnings per share (EPS) of 9 cents in the fourth quarter of 2014, which managed to beat the Zacks Consensus Estimate by a couple of cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), AFFX: 11.45 (+0.02), SURG: 4.44 (-0.02)
4 Impressive Stocks Blowing Away Expectations - Investment Ideas
Todd Bunton - Zacks Investment Research - Thu Feb 05, 12:00AM CST
4 Impressive Stocks Blowing Away Expectations - Investment Ideas
ABMD: 60.39 (+0.46), SMCI: 39.74 (-0.30), SWKS: 81.85 (-0.57), CRUS: 29.36 (+0.01)
Luminex (LMNX): Strong Buy on Solid Q4 & Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 6:32PM CST
On Feb 4, 2015, Zacks Investment Research raised Luminex Corp (LMNX) to a Zacks Rank #1 (Strong Buy).
ABMD: 60.39 (+0.46), TMO: 127.61 (+0.78), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Varian Medical's ProBeam Proton Therapy Now in Denmark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 2:43PM CST
In addition to the ProBeam system, Varian Medical Systems Inc. (VAR) will provide the Denmark center with its ARIA information management software.
ABMD: 60.39 (+0.46), VAR: 92.65 (+0.03), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Allscripts Sunrise EHR: IHMC's Choice for Flagship Hospital - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 1:57PM CST
Allscripts recently announced that its Sunrise Acute Care has been selected by Texas-based International Hospital Management Corp. (IHMC).
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), MDRX: 11.80 (+0.04), SURG: 4.44 (-0.02)
Bioanalytical Systems' Breakeven Q1 Earnings, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:00AM CST
Bioanalytical Systems (BASI) reported adjusted breakeven earnings per share (EPS) in the first quarter of fiscal 2015, which was lower by 3 cents on a year-over-year basis
ABMD: 60.39 (+0.46), BASI: 2.06 (+0.18), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Alere (ALR) Disappoints; Misses on Earnings, Revenues in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:44AM CST
Alere Inc. (ALR) reported disappointing fourth-quarter 2014 results with both its top and bottom line missing the Zacks Consensus Estimate.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ALR: 43.40 (-0.40), SURG: 4.44 (-0.02)
Cepheid Strong on Q4, Global Expansion; Currency Woes Stay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 1:09PM CST
Cepheid (CPHD) reported adjusted breakeven earnings per share in the quarter, which compared favorably with the Zacks Consensus Estimate of a loss of 14 cents.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), CPHD: 59.62 (+0.72), LMNX: 15.45 (+0.02)
Acadia Healthcare Posts In-Line Q4 Earnings, Revenue Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:54AM CST
Acadia Healthcare Company (ACHC) reported fourth-quarter 2014 adjusted earnings (EPS) of 46 cents per share, which surged an impressive 58.6% year over year.
ACHC: 63.20 (-0.45), ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Thoratec (THOR) Catches Eye: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:08AM CST
Thoratec Corp. (THOR) was a big mover last session, as the company saw its shares rise over 8% on the day.
ABMD: 60.39 (+0.46), THOR: 40.01 (+0.54)
MVPVets Veterans Program Recognizes Top Donors in 2014
GlobeNewswire - Wed Feb 11, 9:55AM CST
MVPVets (The MedTech and BioTech Veterans Program) is recognizing top donors for the program in 2014. MVPVets, a 501(c)(3) nonprofit organization, provides training and mentorship to veterans and transitioning military in order to help them recareer into rewarding jobs in Life Sciences industry. Wholly sponsored by grants and the Medical Device and Technology, Biological Technological, Pharmaceutical, and other segments within the Life Sciences industry, the program partners with host companies for one-day recareering seminars and provides virtual mentorship and training through the MVPVets collaborative online portal.
ABMD: 60.39 (+0.46)
Thoratec Beats Q4 Earnings and Revenues, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:45AM CST
Shares of Thoratec Corp. (THOR) rallied 4.37% ($1.59) to $38.00 after the company reported impressive fourth-quarter financial numbers.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), THOR: 40.01 (+0.54), LMNX: 15.45 (+0.02)
Opko Health (OPK) in Focus: Stock Jumps 5.3% - Tale of the Tape
Zacks Research Stuff - Zacks Investment Research - Tue Feb 10, 8:18AM CST
Opko Health, Inc. (OPK) was a big mover last session, as the company saw its shares rise over 5% on the day.
ABMD: 60.39 (+0.46), OPK: 13.80 (-0.28)
Sirona Dental Q1 Earnings and Revenues Top Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:45AM CST
Following the earnings release, shares of Sirona Dental Systems Inc. (SIRO) dropped nearly 3.4% to close at $90.25 till the last trading session.
SIRO: 91.06 (+0.18), ABMD: 60.39 (+0.46), PDCO: 50.65 (-0.16), HSIC: 143.18 (+0.72)
Fluidigm Q4 Loss Narrower Than Expected, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:10AM CST
Following the earnings announcement on Feb 5, shares of Fluidigm Corp (FLDM) rallied nearly 2.8% to open at $39.85 on Friday.
ABMD: 60.39 (+0.46), FLDM: 37.93 (-0.47), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Accuray's TomoTherapy Gains Traction in Latin America (Revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:00AM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ARAY: 8.00 (+0.24), LMNX: 15.45 (+0.02)
Invacare (IVC) Reports Narrower Q4 Loss, Beats on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:29AM CST
Invacare Corp. (IVC) reported adjusted loss of 12 cents per share in the fourth quarter of 2014, which was narrower than the Zacks Consensus Estimate of a loss of 23 cents
ABMD: 60.39 (+0.46), IVC: 17.13 (+0.15), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Mettler-Toledo Tops Earnings, Revenues on Margin Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:16AM CST
Mettler-Toledo International Inc. (MTD) reported an impressive fourth-quarter 2014 wherein adjusted EPS of $4.24 beat the Zacks Consensus Estimate by 9 cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02), MTD: 307.00 (-0.13)
Accuray's TomoTherapy Gains Traction in Latin America - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 5:25PM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02), ARAY: 8.00 (+0.24)
Affymetrix (AFFX) Earnings, Revenues Outshine Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 8:56AM CST
Affymetrix Inc. (AFFX) reported adjusted earnings per share (EPS) of 9 cents in the fourth quarter of 2014, which managed to beat the Zacks Consensus Estimate by a couple of cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), AFFX: 11.45 (+0.02), SURG: 4.44 (-0.02)
4 Impressive Stocks Blowing Away Expectations - Investment Ideas
Todd Bunton - Zacks Investment Research - Thu Feb 05, 12:00AM CST
4 Impressive Stocks Blowing Away Expectations - Investment Ideas
ABMD: 60.39 (+0.46), SMCI: 39.74 (-0.30), SWKS: 81.85 (-0.57), CRUS: 29.36 (+0.01)
Luminex (LMNX): Strong Buy on Solid Q4 & Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 6:32PM CST
On Feb 4, 2015, Zacks Investment Research raised Luminex Corp (LMNX) to a Zacks Rank #1 (Strong Buy).
ABMD: 60.39 (+0.46), TMO: 127.61 (+0.78), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
